Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone

Overview of attention for article published in PLOS ONE, April 2009

Altmetric Badge

Mentioned by

patent: 12 patents

Citations

dimensions_citation: 167 Dimensions

Readers on

mendeley: 110 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 12 patents that reference this research output.

PLOS

Article Metrics

Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone

Mentioned by

Citations

Readers on

Compositions and methods for growth factor modulation

Grant US-11827698-B2

United States of America

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

Application EP-3816625-A1

European Patent Office

Compositions and methods for growth factor modulation

Grant US-10981981-B2

United States of America

Compositions and methods for growth factor modulation

Grant US-10597443-B2

United States of America

2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

Application US-10155763-B2

United States of America

Compositions and methods for growth factor modulation

Grant US-9758576-B2

United States of America

ANTI-TGF-BETA INDUCTION OF BONE CELL FUNCTION AND BONE GROWTH

Application EP-3141561-A3

European Patent Office

Compositions and methods for growth factor modulation

Grant US-9580500-B2

United States of America

Compositions and methods for growth factor modulation

Grant US-9573995-B2

United States of America

Compositions and methods for growth factor modulation

Grant US-9399676-B2

United States of America

Quinolinone derivatives

Grant US-9061997-B2

United States of America

COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION

Application WO-2014182676-A2

World Intellectual Property Organisation (WIPO)